Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025)
Cardiovascular diseases are one of the main causes of mortality and disability among the population of the member countries of the Eurasian Association of Cardiology, which is directly related to the high prevalence of risk factors for atherosclerosis, among which dyslipidemia plays a leading role....
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
InterMedservice
2025-06-01
|
| Series: | Евразийский Кардиологический Журнал |
| Subjects: | |
| Online Access: | https://www.heartj.asia/jour/article/view/6515 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849402513648779264 |
|---|---|
| author | M. V. Ezhov V. V. Kukharchuk T. V. Balakhonova V. S. Gurevich I. V. Sergienko A. A. Sokolov A. A. Semenkin I. I. Shaposhnik N. M. Akhmedzhanov O. L. Barbarash M. G. Bubnova M. I. Voevoda A. S. Galyavich S. Ya. Eregin G. A. Konovalov V. A. Korneva S. N. Pokrovsky A. A. Raskurazhev V. V. Skibitsky M. M. Tanashyan I. E. Chazova A. E. Filippov U. V. Chubykina S. S. Yakushin |
| author_facet | M. V. Ezhov V. V. Kukharchuk T. V. Balakhonova V. S. Gurevich I. V. Sergienko A. A. Sokolov A. A. Semenkin I. I. Shaposhnik N. M. Akhmedzhanov O. L. Barbarash M. G. Bubnova M. I. Voevoda A. S. Galyavich S. Ya. Eregin G. A. Konovalov V. A. Korneva S. N. Pokrovsky A. A. Raskurazhev V. V. Skibitsky M. M. Tanashyan I. E. Chazova A. E. Filippov U. V. Chubykina S. S. Yakushin |
| author_sort | M. V. Ezhov |
| collection | DOAJ |
| description | Cardiovascular diseases are one of the main causes of mortality and disability among the population of the member countries of the Eurasian Association of Cardiology, which is directly related to the high prevalence of risk factors for atherosclerosis, among which dyslipidemia plays a leading role. The previous version of the Eurasian Recommendations for the Diagnosis and correction of lipid metabolism disorders for the prevention and treatment of atherosclerosis was presented in 2020. Over the past 5 years, approaches to risk stratification, diagnosis of subclinical atherosclerosis, and correction of dyslipidemia using various classes of lipid-lowering drugs have changed significantly. Among the initial updates, proposals should be highlighted for determining the blood lipid level in each adult or upon reaching the age of 18, using the SCORE and/or SCORE2 scales to stratify cardiovascular risk, and non-invasive imaging techniques to assess subclinical atherosclerosis. In the sections devoted to therapy, fixed combinations of lipid-lowering drugs, inclisiran, and bempedoic acid are presented. The section on the prevalence, significance and approaches to correction of hypertriglyceridemia, as well as the section on extracorporeal hemocorrection, has been expanded. A chapter on lipoprotein(a) is introduced. Sections on correction of dyslipidemia in cerebrovascular diseases, heart transplantation and HIV infection are presented. These recommendations will be useful to the phisicians of all specialties for the effective management of their patients. |
| format | Article |
| id | doaj-art-b8a6c31a74cb4e0caa8d8b167a074261 |
| institution | Kabale University |
| issn | 2225-1685 2305-0748 |
| language | Russian |
| publishDate | 2025-06-01 |
| publisher | InterMedservice |
| record_format | Article |
| series | Евразийский Кардиологический Журнал |
| spelling | doaj-art-b8a6c31a74cb4e0caa8d8b167a0742612025-08-20T03:37:31ZrusInterMedserviceЕвразийский Кардиологический Журнал2225-16852305-07482025-06-010263410.38109/2225-1685-2025-2-6-346377Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025)M. V. Ezhov0V. V. Kukharchuk1T. V. Balakhonova2V. S. Gurevich3I. V. Sergienko4A. A. Sokolov5A. A. Semenkin6I. I. Shaposhnik7N. M. Akhmedzhanov8O. L. Barbarash9M. G. Bubnova10M. I. Voevoda11A. S. Galyavich12S. Ya. Eregin13G. A. Konovalov14V. A. Korneva15S. N. Pokrovsky16A. A. Raskurazhev17V. V. Skibitsky18M. M. Tanashyan19I. E. Chazova20A. E. Filippov21U. V. Chubykina22S. S. Yakushin23E.I. Chazov National Medical Research Center of CardiologyE.I. Chazov National Medical Research Center of CardiologyE.I. Chazov National Medical Research Center of CardiologyMechnikov’s North-west State Medical University; St. Petersburg State UniversityE.I. Chazov National Medical Research Center of CardiologyE.I. Chazov National Medical Research Center of CardiologyOmsk State Medical UniversitySouth Ural State Medical UniversityNational Medical Research Center for Therapy and Preventive MedicineResearch Institute for Complex Issues of Cardiovascular DiseasesNational Medical Research Center for Therapy and Preventive MedicineFederal Research Center for Fundamental and Translational MedicineDepartment of CardiologyYaroslavl State Medical UniversityCenter for Diagnostics and Innovative Medical Technologies of the MEDSI Clinical Diagnostic CenterPetrozavodsk State UniversityE.I. Chazov National Medical Research Center of CardiologyScientific Center of NeurologyKuban State Medical UniversityScientific Center of NeurologyE.I. Chazov National Medical Research Center of CardiologySaint Petersburg State UniversityE.I. Chazov National Medical Research Center of CardiologyI.P. Pavlov Ryazan State Medical UniversityCardiovascular diseases are one of the main causes of mortality and disability among the population of the member countries of the Eurasian Association of Cardiology, which is directly related to the high prevalence of risk factors for atherosclerosis, among which dyslipidemia plays a leading role. The previous version of the Eurasian Recommendations for the Diagnosis and correction of lipid metabolism disorders for the prevention and treatment of atherosclerosis was presented in 2020. Over the past 5 years, approaches to risk stratification, diagnosis of subclinical atherosclerosis, and correction of dyslipidemia using various classes of lipid-lowering drugs have changed significantly. Among the initial updates, proposals should be highlighted for determining the blood lipid level in each adult or upon reaching the age of 18, using the SCORE and/or SCORE2 scales to stratify cardiovascular risk, and non-invasive imaging techniques to assess subclinical atherosclerosis. In the sections devoted to therapy, fixed combinations of lipid-lowering drugs, inclisiran, and bempedoic acid are presented. The section on the prevalence, significance and approaches to correction of hypertriglyceridemia, as well as the section on extracorporeal hemocorrection, has been expanded. A chapter on lipoprotein(a) is introduced. Sections on correction of dyslipidemia in cerebrovascular diseases, heart transplantation and HIV infection are presented. These recommendations will be useful to the phisicians of all specialties for the effective management of their patients.https://www.heartj.asia/jour/article/view/6515dyslipidemiaatherosclerosislow-density lipoprotein cholesteroltriglycerideslipid-lowering therapy |
| spellingShingle | M. V. Ezhov V. V. Kukharchuk T. V. Balakhonova V. S. Gurevich I. V. Sergienko A. A. Sokolov A. A. Semenkin I. I. Shaposhnik N. M. Akhmedzhanov O. L. Barbarash M. G. Bubnova M. I. Voevoda A. S. Galyavich S. Ya. Eregin G. A. Konovalov V. A. Korneva S. N. Pokrovsky A. A. Raskurazhev V. V. Skibitsky M. M. Tanashyan I. E. Chazova A. E. Filippov U. V. Chubykina S. S. Yakushin Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025) Евразийский Кардиологический Журнал dyslipidemia atherosclerosis low-density lipoprotein cholesterol triglycerides lipid-lowering therapy |
| title | Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025) |
| title_full | Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025) |
| title_fullStr | Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025) |
| title_full_unstemmed | Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025) |
| title_short | Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025) |
| title_sort | eurasian association of cardiology eac russian national atherosclerosis society rnas guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis 2025 |
| topic | dyslipidemia atherosclerosis low-density lipoprotein cholesterol triglycerides lipid-lowering therapy |
| url | https://www.heartj.asia/jour/article/view/6515 |
| work_keys_str_mv | AT mvezhov eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT vvkukharchuk eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT tvbalakhonova eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT vsgurevich eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT ivsergienko eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT aasokolov eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT aasemenkin eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT iishaposhnik eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT nmakhmedzhanov eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT olbarbarash eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT mgbubnova eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT mivoevoda eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT asgalyavich eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT syaeregin eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT gakonovalov eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT vakorneva eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT snpokrovsky eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT aaraskurazhev eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT vvskibitsky eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT mmtanashyan eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT iechazova eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT aefilippov eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT uvchubykina eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 AT ssyakushin eurasianassociationofcardiologyeacrussiannationalatherosclerosissocietyrnasguidelinesforthediagnosisandcorrectionofdyslipidemiaforthepreventionandtreatmentofatherosclerosis2025 |